Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Veracyte reported $72K in Ordinary Share Capital for its fiscal quarter ending in March of 2023.

Ordinary Share Capital Change
Agenus AGEN:US USD 3.42M 361K
Agilent A:US USD 3M 0
Anika Therapeutics ANIK:US USD 147K 1000
Arrowhead Research ARWR:US USD 199K 0
Exact Sciences EXAS:US USD 1.8M 19K
Heron Therapeutics HRTX:US USD 1.19M 2K
Immunogen IMGN:US USD 2.26M 1000
Laboratory Of America LH:US USD 8.1M 0
Myriad Genetics MYGN:US USD 800K 0
Rigel Pharmaceuticals RIGL:US USD 174K 0
Roche Holding ROG:VX CHF 107M 0
Sangamo BioSciences SGMO:US USD 1.72M 50K
Siemens SIE:GR EUR 2.4B 150M
Sonic Healthcare SHL:AU AUD 3.76B 106.79M
Veracyte VCYT:US USD 72K 0
Waters WAT:US USD 1.63M 2K